Your browser doesn't support javascript.
loading
Long-term risk-factor control and secondary prevention are insufficient after first TIA: Results from QregPV.
Bager, Johan-Emil; Jood, Katarina; Nordanstig, Annika; Andersson, Tobias; Nåtman, Jonatan; Hjerpe, Per; Rosengren, Annika; Mourtzinis, Georgios.
Afiliación
  • Bager JE; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Jood K; Department of Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Nordanstig A; Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Andersson T; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Nåtman J; Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hjerpe P; Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Rosengren A; Regionhälsan R&D Centre, Skaraborg Primary Care, Skövde, Sweden.
  • Mourtzinis G; Centre of Registers Västra Götaland, Gothenburg, Sweden.
Eur Stroke J ; 9(1): 154-161, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38032016
ABSTRACT

INTRODUCTION:

Long-term risk-factor control and secondary prevention are not well characterized in patients with a first transient ischemic attack (TIA). With baseline levels as reference, we compared primary-care data on blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), smoking, and use of antihypertensives, statins and antiplatelet treatment/oral anticoagulation (APT/OAC) during 5 years after a first TIA. PATIENTS AND

METHODS:

Patients in QregPV, a Swedish primary-care register for the Region of Västra Götaland, with a first TIA discharge diagnosis from wards proficient in stroke care 2010 to 2012 were identified and followed up to 5 years. BP, LDL-C, smoking, use of antihypertensives, statins, APT/OAC, and achievement of target levels were calculated. We used logistic mixed-effect models to analyze the effect of follow-up over time on risk-factor control and secondary prevention treatment.

RESULTS:

We identified 942 patients without prior cerebrovascular disease who had a first TIA. Compared to baseline, the first year of follow-up was associated with improvements in concomitant attainment of BP <140/90 mmHg, LDL-C < 2.6 mmol/L and non-smoking, which rose from 20% to 33% (OR 2.08, 95% CI 1.38-3.13), but then stagnated in years 2-5. In the first year of follow-up, 47% of patients had complete secondary prevention treatment (antihypertensives, APT/OAC and statin), but continued follow-up was associated with a yearly decrease in secondary prevention treatment (OR 0.94, 95% CI 0.94-0.98).

CONCLUSION:

Risk-factor control was inadequate, leaving considerable potential for improved secondary prevention treatment after a first TIA in Swedish patients followed up to 5 years.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Ataque Isquémico Transitorio / Inhibidores de Hidroximetilglutaril-CoA Reductasas Límite: Humans Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Ataque Isquémico Transitorio / Inhibidores de Hidroximetilglutaril-CoA Reductasas Límite: Humans Idioma: En Revista: Eur Stroke J Año: 2024 Tipo del documento: Article País de afiliación: Suecia
...